Skip to content
lifestyle.side.cr
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Matisse Pharmaceuticals
Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development
September 17, 2026
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
June 9, 2026
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
May 19, 2026